ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Investigating Cohn Records Leak

August 15, 1986

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

Researchers Discover Bacteria Common in Colon Cancer Tissue

October 28, 2011

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

Evidence “Weak” Linking EMFs, cancer

June 25, 1999